Gerresheimer Announces Pre-Fillable Syringe Product Line Expansion
Gerresheimer has announced it will be expanding its ClearJect product line of pre-fillable syringes with a new 2.25-mL cyclic olefin polymer (COP) staked in needle (SIN) syringe.
German-based Gerresheimer has announced it will be expanding its ClearJect product line of pre-fillable syringes with a new 2.25-mL cyclic olefin polymer (COP) staked in needle (SIN) syringe, which will be produced in Pfreimd, Germany along with the 1-mL version.
COP is a high-performance polymer, which means that the new pre-fillable syringe, the Gx RTF ClearJect 2.25-mL syringe, is suitable for use as primary packaging for biopharmaceutical products. Additionally, as the polymer is considered to be well resistant to breakages, the syringes are suitable for use with aggressive or toxic products.
The range of COP syringes from Gerresheimer are designed to ISO 11040-6 standard and have been registered. Furthermore, the syringes have been engineered to also be used in autoinjectors.
More information on the Gx RTF ClearJect range of pre-fillable syringes is available on the company’s website.
Source: Gerresheimer
EMA Recommends Imfinzi-Based Perioperative Regimen for Treating Resectable NSCLC
March 10th 2025The committee’s recommendation is based on results from a Phase III trial in which Imfinzi demonstrated a reduced risk of recurrence, progression, or death by 32% compared to neoadjuvant chemotherapy alone.
International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma
March 8th 2025In an interview with BioPharm International®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
